Trending Stock News

Awm Investment Company Has Lowered Its Aratana Therapeutics (PETX) Holding; Antipodean Advisors Raised Its Iac Interactivecorp (IACI) Stake

Aratana Therapeutics, Inc. (NASDAQ:PETX) Logo

Antipodean Advisors Llc increased Iac Interactivecorp (IACI) stake by 20.31% reported in 2017Q4 SEC filing. Antipodean Advisors Llc acquired 6,500 shares as Iac Interactivecorp (IACI)’s stock 0.00%. The Antipodean Advisors Llc holds 38,500 shares with $4.71 million value, up from 32,000 last quarter. Iac Interactivecorp now has $ valuation. It closed at $50.68 lastly. It is down 0.00% since April 21, 2017 and is . It has underperformed by 11.55% the S&P500.

Awm Investment Company Inc decreased Aratana Therapeutics Inc. (PETX) stake by 5.45% reported in 2017Q4 SEC filing. Awm Investment Company Inc sold 85,100 shares as Aratana Therapeutics Inc. (PETX)’s stock declined 19.44%. The Awm Investment Company Inc holds 1.48M shares with $7.77M value, down from 1.56M last quarter. Aratana Therapeutics Inc. now has $232.94 million valuation. The stock increased 2.21% or $0.11 during the last trading session, reaching $5.08. About 338,527 shares traded. Aratana Therapeutics, Inc. (NASDAQ:PETX) has declined 14.71% since April 21, 2017 and is downtrending. It has underperformed by 26.26% the S&P500.

Among 5 analysts covering InterActiveCorp (NASDAQ:IACI), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. InterActiveCorp had 14 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Axiom Capital given on Tuesday, September 22. UBS maintained the stock with “Buy” rating in Friday, August 14 report. Needham maintained ** SEE<IAC> (NASDAQ:IACI) on Friday, November 20 with “Buy” rating. The rating was initiated by Susquehanna on Monday, January 18 with “Positive”. The rating was maintained by Needham on Wednesday, October 28 with “Buy”. The firm has “Sector Perform” rating given on Wednesday, October 28 by RBC Capital Markets. The stock has “Buy” rating by Benchmark on Wednesday, July 29. Guggenheim initiated the shares of IACI in report on Tuesday, October 13 with “Buy” rating. The stock has “Buy” rating by Axiom Capital on Tuesday, January 12. The stock of ** SEE<IAC> (NASDAQ:IACI) has “Buy” rating given on Saturday, August 22 by Benchmark.

Since January 2, 2018, it had 0 insider buys, and 1 sale for $7.92 million activity. WINIARSKI GREGG also sold $7.92M worth of ** SEE<IAC> (NASDAQ:IACI) shares.

Investors sentiment decreased to 1.06 in Q4 2017. Its down 0.23, from 1.29 in 2017Q3. It dropped, as 45 investors sold IACI shares while 120 reduced holdings. 67 funds opened positions while 108 raised stakes. 68.35 million shares or 6.61% less from 73.19 million shares in 2017Q3 were reported. Reliance Tru Co Of Delaware invested in 0.04% or 1,916 shares. Moreover, Verition Fund Management Ltd Liability has 0.16% invested in ** SEE<IAC> (NASDAQ:IACI). Ruane Cunniff And Goldfarb reported 801,930 shares. California Public Employees Retirement Sys invested in 185,582 shares or 0.03% of the stock. Amer International Grp Inc Inc holds 1,653 shares or 0% of its portfolio. Schwab Charles Inv has invested 0.03% in ** SEE<IAC> (NASDAQ:IACI). Ww Asset stated it has 0.01% in ** SEE<IAC> (NASDAQ:IACI). Columbus Circle Investors invested in 249,844 shares or 0.58% of the stock. Qs Limited Liability Corporation holds 0% in ** SEE<IAC> (NASDAQ:IACI) or 707 shares. Neuberger Berman Grp Lc has 8,302 shares. 36,986 were reported by Wellington Mngmt Group Inc Llp. The Massachusetts-based Boston has invested 0.31% in ** SEE<IAC> (NASDAQ:IACI). Melvin Mgmt Ltd Partnership holds 0.38% or 325,000 shares. Goldman Sachs Gru has invested 0.06% in ** SEE<IAC> (NASDAQ:IACI). First Retail Bank Of Omaha holds 55,620 shares.

Since January 11, 2018, it had 0 insider purchases, and 2 selling transactions for $250,341 activity. 30,000 shares were sold by TOOMAN CRAIG A, worth $158,040. $92,301 worth of Aratana Therapeutics, Inc. (NASDAQ:PETX) was sold by St Peter Steven.

Among 8 analysts covering Aratana Therapeutics (NASDAQ:PETX), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Aratana Therapeutics had 22 analyst reports since July 29, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Buy” rating and $11 target in Wednesday, March 16 report. The firm earned “Buy” rating on Friday, November 3 by Jefferies. The firm earned “Buy” rating on Tuesday, January 16 by H.C. Wainwright. The rating was initiated by Lake Street on Wednesday, July 29 with “Buy”. The rating was maintained by Stifel Nicolaus on Monday, October 23 with “Hold”. The rating was maintained by Jefferies with “Buy” on Wednesday, November 15. Jefferies maintained the shares of PETX in report on Friday, August 4 with “Buy” rating. The stock of Aratana Therapeutics, Inc. (NASDAQ:PETX) has “Hold” rating given on Monday, December 18 by Stifel Nicolaus. Barclays Capital maintained the shares of PETX in report on Thursday, August 11 with “Overweight” rating. The firm has “Hold” rating given on Wednesday, December 27 by C.L. King.

Awm Investment Company Inc increased Impinj Inc. stake by 24,500 shares to 515,224 valued at $11.61 million in 2017Q4. It also upped American Superconductor Corp. stake by 547,888 shares and now owns 1.15 million shares. Asure Software Inc. (NASDAQ:ASUR) was raised too.

Aratana Therapeutics, Inc. (NASDAQ:PETX) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *